Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Antonio Vega Mateos, Héctor Alejandro Vaquera Alfaro, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Olga Cantu, Andres Gomez-De Leon, David Gomez-Almaguer, Luz Tarin-Arzaga, César Homero Gutierrez-Aguirre, Perla R. Colunga-Pedraza

Blood (2024) 144 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2024-208831

Published: 2024

Journal Articles

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Alexia Gonzalez, Ana Laura Varela Constantino, Nereida Méndez-Ramírez, Fernando J Medina-Olivares, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Colunga-Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 376.

https://doi.org/10.1182/blood-2024-208879

Published: 2024

Journal Articles

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Yadith Karina Lopez-Garcia, Sara Redondo Velao, Andres Gomez-De Leon, Irene García-Cadenas, Héctor Alejandro Vaquera Alfaro, Perla R. Colunga-Pedraza, Albert Esquirol, César Homero Gutierrez-Aguirre, José Carlos Jaime-Pérez, Jorge Sierra, Olga Cantu, Javier Briones, David Gomez-Almaguer, Rodrigo Martino

Blood (2024) 144 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2024-210332

Published: 2024

Journal Articles

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Ana L. Varela-Constantino, Michelle Morcos, Andres Noyola-Perez, Nereida Méndez-Ramírez, Eli Fuentes-Chavez, Rosario Salazar-Riojas, César Homero Gutierrez-Aguirre, Olga Cantu, Perla Rocio Colunga Pedraza, Luz Tarin-Arzaga, Xitlaly Judith Gonzalez Leal, Elías Eugenio Gonzalez-López, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 4873.

https://doi.org/10.1182/blood-2024-211711

Published: 2024

Journal Articles

Reassessing Blood Product Irradiation in Haploidentical Transplantation: A Single-Center Perspective

Juan Pablo Martinez, Yesica Aylen López-Mora, Rosario Salazar-Riojas, Dalila Marisol Alvarado-Navarro, Ana Karen Hernández-Navarro, Yair Omar Chávez-Estrada, Andres Gomez-De Leon, César Homero Gutierrez-Aguirre, Perla R. Rocio Colunga-Pedraza, Olga Cantu, José Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 4030.

https://doi.org/10.1182/blood-2024-205373

Published: 2024

Journal Articles

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Ana Cristina Tejada Vasquez, César Homero Gutierrez-Aguirre, Luis Paulo Ugarte Pelaez, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Perla R. Rocio Colunga-Pedraza, Andres Gomez-De Leon, Olga Cantu, José Carlos Jaime-Pérez, David Gomez-Almaguer

Blood (2024) 144 (Supplement 1): 7395.

https://doi.org/10.1182/blood-2024-209003

Published: 2024

Journal Articles

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Alejandra De las Fuentes-Cepeda, Perla R. Colunga-Pedraza, Héctor Alejandro Vaquera Alfaro, Julia Esther Colunga-Pedraza, Andres Gomez-De Leon, Michelle Morcos, Ana Cristina Tejada Vasquez, Yadith Karina Lopez-Garcia, Gerardo Garcia-Salas, Antonio Vega Mateos, César Homero Gutierrez-Aguirre, Olga Cantu, Luz Tarin-Arzaga, Consuelo Mancías-Guerra, David Gomez-Almaguer, Guillermo José Ruiz-Arguelles

Blood (2024) 144 (Supplement 1): 7299.

https://doi.org/10.1182/blood-2024-210921

Published: 2024

Journal Articles

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Gerardo Garcia-Salas, David Gomez-Almaguer, Carlos Reta-Cortéz, Antonio Vega Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, José Carlos Jaime-Pérez, César Homero Gutierrez-Aguirre, Luz Tarin-Arzaga, Perla Colunga-Pedraza, Olga Cantu, Andres Gomez-De Leon

Blood (2024) 144 (Supplement 1): 7119.

https://doi.org/10.1182/blood-2024-210532

Published: 2024

Journal Articles

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

Héctor Alejandro Vaquera Alfaro, Zulia Guzman-Martínez, Antonio Vega-Mateos, Yadith Karina Lopez-Garcia, Ana Cristina Tejada Vasquez, Gerardo Garcia-Salas, César Homero Gutierrez-Aguirre, Olga Cantu, David Gomez-Almaguer, Perla R. Colunga-Pedraza

Blood (2023) 142 (Supplement 1): 1711.

https://doi.org/10.1182/blood-2023-188171

Published: 2023

Journal Articles

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Juan Carlos Olivares-Gazca, María de Lourdes Pastelín-Martínez, Merittzel Abigail Montes-Robles, Moisés Manuel Gallardo-Pérez, Edgar Jared Hernández-Flores, Max Robles-Nasta, Daniela Sánchez-Bonilla, César Homero Gutierrez-Aguirre, Andres Gomez-De Leon, David Gomez-Almaguer, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Arguelles

Blood (2023) 142 (Supplement 1): 2173.

https://doi.org/10.1182/blood-2023-181489

Published: 2023

Journal Articles

Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease Patients in a Limited-Resource Center in Northeastern Mexico. Single Center Experience

Perla R.R. Colunga-Pedraza, Edgar Ulises Ulises Coronado-Alejandro, Luz María Barbosa Castillo, Fernando De La Garza, Eliezer Tomas Tomas Gomez Gomez, Andres Gomez-De Leon, Julia Esther Colunga Pedraza, Cesar Homero Gutierrez-Aguirre, Olga Graciela Cantú Rodriguez, David Gomez-Almaguer

Blood (2022) 140 (Supplement 1): 12886–12887.

https://doi.org/10.1182/blood-2022-165532

Published: 2022

Journal Articles

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Eliezer Tomas Tomas Gomez Gomez, David Gomez Almaguer, Cesar Homero Gutierrez-Aguirre, Perla R.R. Colunga-Pedraza, Luz Tarin-Arzaga, Jose Carlos Jaime, Edgar Ulises Coronado, Fernando De La Garza, Estefania Guadarrama Rendon, Santiago Calzada Davila

Blood (2022) 140 (Supplement 1): 7710–7711.

https://doi.org/10.1182/blood-2022-163772

Published: 2022

Journal Articles

Low-Dose Nivolumab Plus Brentuximab Vedotin As a Bridge to Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma

Perla R. R. Colunga-Pedraza, Edgar Ulises Coronado-Alejandro, Fernando De La Garza, Eliezer Tomas Gomez Gomez, Andres Gomez-De Leon, Julia Esther Colunga Pedraza, Cesar Homero Gutierrez-Aguirre, Olga Graciela Cantu Rodriguez, David Gomez-Almaguer

Blood (2021) 138 (Supplement 1): 4534.

https://doi.org/10.1182/blood-2021-153267

Published: 2021

Journal Articles

A Tale of Two Centers: Access to Private Care Improves Outcomes in Allogeneic Transplant Recipients

Xitlaly Judith Gonzalez Leal, Elías Eugenio González López, Felipe Soto-Lanza, Gerardo A De la Rosa-Flores, Perla R. R. Colunga-Pedraza, Anna Cecilia Rodríguez-Zuñiga, Cesar Homero Gutierrez-Aguirre, Olga Graciela Cantu Rodriguez, Luz del Carmen Tarin Arzaga, David Gomez-Almaguer, Andres Gomez-De Leon

Blood (2021) 138 (Supplement 1): 4890.

https://doi.org/10.1182/blood-2021-154178

Published: 2021

Journal Articles

Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study

Perla R. R. Colunga-Pedraza, Mónica Bustillos Muñoz, Fernando De La Garza, Andres Gomez-De Leon, Edgar Ulises Coronado-Alejandro, Eliezer Tomas Gomez Gomez, Ana Varela-Constantino, Gerardo A De la rosa-Flores, Olga Graciela Cantu Rodriguez, Cesar Homero Gutierrez-Aguirre, Luz del Carmen Tarín Arzaga, David Gomez-Almaguer

Blood (2021) 138 (Supplement 1): 1014.

https://doi.org/10.1182/blood-2021-149769

Published: 2021

Journal Articles

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Perla R. Colunga Pedraza, MD, Julia Esther Colunga Pedraza, MD, Andres Gomez-De Leon, MD, Mónica Bustillos Muñoz, MD, Karen Lorena Osorno-Rodriguez, MD, Jose Angel Hawing, MD, Oscar Gonzalez Llano, MD, Yajaira Valentine Jimenez-Antolinez, MD, Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-142035

Published: 2020

Journal Articles

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

Cesar Homero Gutierrez-Aguirre, PhD, Olga Graciela Cantu Rodriguez, MD, Fernando De la Garza-Salazar, MD, Rosario Salazar Riojas, Chem., Andres Gomez De Leon, MD, Perla R. Colunga Pedraza, MD, Geraldina Guerrero-González, PhD, Jose Carlos Jaime, MD PhD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, David Gomez-Almaguer, MD, Oscar Gonzalez Llano, MD, Consuelo Mancias, MD

Blood (2019) 134 (Supplement_1): 1967.

https://doi.org/10.1182/blood-2019-131791

Published: 2019

Journal Articles

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Perla R. Colunga Pedraza, MD, Andrés Gómez-De León, MD, Mónica Bustillos Muñoz, MD, Diana E Garcia-Camarillo, MD, Rosario Salazar Riojas, Chem., Leslie Silva López, Quem., Olga Graciela Cantu Rodriguez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 2057.

https://doi.org/10.1182/blood-2019-131627

Published: 2019

Journal Articles

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Andrés Gómez-De León, MD, Dalila Marisol Alvarado Navarro, MD, Cesar O Pezina Cantú, MD, Perla R. Colunga Pedraza, MD, David Gomez-Almaguer, MD, Rosario Salazar Riojas, Chem., Olga Graciela Cantu Rodriguez, MD, Luz del Carmen Tarín Arzaga, MD, Jose Carlos Jaime, MD PhD, Cesar Homero Gutierrez-Aguirre, PhD

Blood (2019) 134 (Supplement_1): 4476.

https://doi.org/10.1182/blood-2019-129516

Published: 2019

Journal Articles

Tocilizumab for Prophylaxis of Cytokine Release Syndrome after Outpatient-Based Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation

Oscar Marquez, MD, Andrés Gómez-De León, MD, Perla R. Colunga Pedraza, MD, Cesar O Pezina Cantú, MD, Diana E Garcia-Camarillo, MD, Paola Santana-Hernandez, MD, Cesar Homero Gutierrez-Aguirre, PhD, David Gomez-Almaguer, MD

Blood (2019) 134 (Supplement_1): 5624.

https://doi.org/10.1182/blood-2019-132088

Published: 2019

NARROW

Low-Dose Nivolumab Plus AVD As Front-Line Therapy for Classical Hodgkin's Lymphoma: Preliminary Results of a Phase 2 Trial

Lowering Conditioning Intensity in Fit Adolescents and Adults with Lymphoblastic Leukemia without Residual Disease Undergoing Transplantation: A Proof of Concept

Efficacy and Safety of Reduced-Doses of Post-Transplant Cyclophosphamide in Matched Peripheral Blood Stem Cell Transplantation, a Multicenter Study

Optimizing Conditioning Intensity to Disease Burden in Adults with Acute Myeloid Leukemia Undergoing Transplantation: Results of a Prospective Multicenter Study

Reassessing Blood Product Irradiation in Haploidentical Transplantation: A Single-Center Perspective

Efficacy of Outpatient Haploidentical Transplantation in Patients with Refractory Hodgkin Lymphoma

Outpatient Care Dynamics after Allogeneic Transplantation: Reasons for Hospitalization and Early Mortality in a Latin American Transplant Center

Effectiveness of Single-Dose Plerixafor in Enhancing Peripheral Blood Progenitor Cell Yield and Rate of Second Collection in Autologous Transplant

Optimizing Resources: Low-Dose Nivolumab Combinations in the Management of Relapsed/Refractory Hodgkin Lymphoma, a Real-World Experience

The Doses of Post-Transplantation Cyclophosphamide in Haploidentical Stem Cell Allografts Can be Reduced

Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease Patients in a Limited-Resource Center in Northeastern Mexico. Single Center Experience

Is VTD the Best First Line Therapy for Multiple Myeloma in an Environment with Limited Resources? an Analysis of Outcomes and Costs

Low-Dose Nivolumab Plus Brentuximab Vedotin As a Bridge to Stem Cell Transplantation in Relapsed/Refractory Classical Hodgkin Lymphoma

A Tale of Two Centers: Access to Private Care Improves Outcomes in Allogeneic Transplant Recipients

Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study

Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care

Moral Distress, Anxiety, and Others Physical Symptoms Related to Hematopoietic Stem Cell Donation

The Road to Day 0: Identification of Barriers from HLA Typing to Transplantation in the Era of Haploidentical Grafts and Post-Transplant Cyclophosphamide

Incorporating Reduced-Dose Plerixafor to a Preemptive Mobilization Algorithm Increases Access to Autologous Transplantation in a Limited-Resource Setting

Tocilizumab for Prophylaxis of Cytokine Release Syndrome after Outpatient-Based Haploidentical T-Cell Replete Peripheral Blood Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only